India cuts drug approval timelines and removes pre-clinical approval requirement
→Drug approvals must complete within 120–150 days
Change
India reduced clinical trial approval timelines to 120–135 days, capped marketing approvals at 150 days and removed mandatory pre-clinical approval.
Why it matters
Regulatory timelines compress significantly, requiring faster dossier preparation and shifting compliance checks into later stages.
Implications
- → Approval timelines shorten — faster market entry
- → Compliance shifts to later stages — regulatory risk redistributes
Full decision brief
Unlock the decision layer.
Get the implications, affected teams, what to watch, and Clarify with AI — so the change becomes easier to act on.
Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you
Source
View on Economic Times